Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Himavanth Gatla"'
Autor:
Himavanth Gatla, Nicholas Uth, Yonatan Levinson, Ali Navaei, Alex Sargent, Senthil Ramaswamy, Inbar Friedrich Ben-Nun
Publikováno v:
Frontiers in Medical Technology, Vol 4 (2022)
Allogeneic T cells are key immune therapeutic cells to fight cancer and other clinical indications. High T cell dose per patient and increasing patient numbers result in clinical demand for a large number of allogeneic T cells. This necessitates a ma
Externí odkaz:
https://doaj.org/article/5eff959ed6b74b978920b0c846a13e67
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/8471f032eb1b47799a52b70a333ed2d2
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background MCY-M11, an anti-mesothelin CAR (Meso-CAR) mRNA transfected PBMC cell product manufactured through Methods MCY-M11 cell product were generated using unmanipulated healthy donor PBMCs (n=5) by transfection of Meso-CAR mRNA using MaxCyte’s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5248d265258b7e5d4946819981e0158d
https://doi.org/10.1136/jitc-2020-sitc2020.0108
https://doi.org/10.1136/jitc-2020-sitc2020.0108
Autor:
Brian H. Ladle, Kathleen L. Gabrielson, Shaoguang Wu, Himavanth Gatla, Sumit Siddharth, Cynthia L. Sears, Sheetal Parida, Guannan Wang, Dipali Sharma
Publikováno v:
Cancer Research. 81:PS19-02
Background: The last decade established significant contributions of microbiome to many organ specific cancers. Existence of distinct breast microbiota has been recently established but their biological impact in breast cancer progression remains elu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d2abe87a9bc1ea70d86770eb77a706b
https://doi.org/10.1158/1538-7445.sabcs20-ps19-02
https://doi.org/10.1158/1538-7445.sabcs20-ps19-02